Case number IPR2017-02063
Pfizer, Inc. v. Genentech, Inc. > Documents
| Date Field | Doc. No. | Party | Description |
|---|---|---|---|
| Oct 3, 2018 | 26 | FINAL WRITTEN DECISION 35 U.S.C. § 318(a) and 37 C.F.R. § 42.73 AND RELATED ORDERS Download | |
| Feb 21, 2018 | 25 | Decision Institution of Inter Partes Review and Grant of Motion for Joinder Download | |
| Feb 2, 2018 | 24 | Second Updated Mandatory Notices Download | |
| Feb 1, 2018 | 23 | Petitioners Updated Mandatory Notices Download | |
| Feb 1, 2018 | 22 | Decision - Petitioner's Motions for Pro Hac Vice Admission of Sarah K. Tsou, Benjamin A. Lasky, Christopher J. Citro, and Mark C. McLennan Download | |
| Jan 5, 2018 | 21 | PO Preliminary Response Download | |
| Jan 5, 2018 | 2101 | Lipton Deposition Transcript Download | |
| Jan 4, 2018 | 19 | Petitioner's Motion for the PHV Admission of Sarah K. Tsou Download | |
| Jan 4, 2018 | 1131 | Declaration in Support of Motion for the PHV Admission of Mark McLennan Download | |
| Jan 4, 2018 | 1130 | Declaration in Support of Motion for the PHV Admission of Benjamin A. Lasky Download | |
| Jan 4, 2018 | 1132 | Declaration in Support of Motion for the PHV Admission of Christopher J. Citro Download | |
| Jan 4, 2018 | 17 | Petitioner's Motion for the PHV Admission of Mark C. McLennan Download | |
| Jan 4, 2018 | 18 | Petitioner's Motion for the PHV Admission of Christopher J. Citro Download | |
| Jan 4, 2018 | 1133 | Declaration in Support of Motion for the PHV Admission of Sarah K. Tsou Download | |
| Jan 4, 2018 | 14 | Petitioner's Updated Power of Attorney Download | |
| Jan 4, 2018 | 20 | Petitioner's First Amended Appendix of Exhibits Download | |
| Jan 4, 2018 | 15 | Petitioner's Updated Mandatory Notices Download | |
| Jan 4, 2018 | 16 | Petitioner's Motion for the PHV Admission of Benjamin A. Lasky Download | |
| Dec 11, 2017 | 13 | Patent Owner's Updated Mandatory Notices Download | |
| Dec 8, 2017 | 12 | Order Conduct of the Proceeding Download | |
| Dec 8, 2017 | 11 | Petitioner's Updated Mandatory Notices Download | |
| Oct 25, 2017 | 10 | Petitioner's Reply In Further Support Of Motion For Joinder Download | |
| Oct 20, 2017 | 9 | Petitioner¿¿¿s Updated Mandatory Notices Download | |
| Oct 6, 2017 | 8 | Patent Owner's Opposition to Motion for Joinder Download | |
| Oct 5, 2017 | 7 | Notice of Joint Stipulation Regarding Joinder with IPR2017-01121 Download | |
| Oct 5, 2017 | 6 | Notice of Accord Filing Date Download | |
| Sep 26, 2017 | 4 | Patent Owner's Mandatory Notices Download | |
| Sep 26, 2017 | 5 | Genentech's Power of Attorney Download | |
| Sep 7, 2017 | 3 | Petitioner's Motion for Joinder Under 35 U.S.C. 315(c), 37 C.F.R. 42.22, AND 42.122(b) Download | |
| Sep 6, 2017 | 2 | Petition for Inter Partes Review of U.S. Patent No. 7,846,441 Download | |
| Sep 6, 2017 | 1129 | Exhibit 1129 Miller (1981) Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 9 Download | |
| Sep 6, 2017 | 1115 | Antibody to HER 2 neu Receptor Blocks DNA Repair After Cisplatin in Human Breast and Ovarian Cancer Cells (Pietras1994). Download | |
| Sep 6, 2017 | 1114 | Phase I/II Trial of Biweekly Paclitaxel and Cisplatin in the Treatment of Metastatic Breast Cancer (Gelmon Apr. 1996). Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 9 Download | |
| Sep 6, 2017 | 1120 | Phase II Study of Weekly Intravenous Recombinant Humanized Anti p185HER2 Monoclonal Antibody in Patients with HER2 neu Overexpressing Metastatic Breast Cancer (Baselga Mar. 1996). Download | |
| Sep 6, 2017 | 1106 | Excerpts from CANCER PRINCIPLES & PRACTICE OF ONCOLOGY (DeVita and Lippincott 1993) Download | |
| Sep 6, 2017 | 1111 | Over Expression and Clinical Taxane Sensitivity A Multivariate Analysis in Patients with Metastatic Breast Cancer (Seidman Mar. 1996). Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 9 Download | |
| Sep 6, 2017 | 1113 | Paclitaxel Couplets with Cyclophosphamide or Cisplatin in Metastatic Breast Cancer (Tocher Feb. 1996). Download | |
| Sep 6, 2017 | 1107 | New Chemotherapeutic Agents for Breast Cancer (Abrams Aug. 1994) Download | |
| Sep 6, 2017 | 1124 | Paclitaxel (Taxol) in Breast Cancer (Arbuck Feb. 1994). Download | |
| Sep 6, 2017 | 1108 | Declaration of Susan D. Hellmann (Dec. 10, 1998) Download | |
| Sep 6, 2017 | 1 | Petitioner's Power of Attorney Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 9 Download | |
| Sep 6, 2017 | 1119 | Anti HER2 Humanized Monoclonal Antibody (MAb) Alone and in Combination with Chemotherapy Against Human Breast Xenografts (Baselga Mar. 1994). Download | |
| Sep 6, 2017 | 1112 | Taxol (Paclitaxel) for Injection Concentrate Download | |
| Sep 6, 2017 | 1123 | Outcomes of Cancer Treatment for Technology Assessment and Cancer Treatment Guidelines (Feb.1996). Download | |
| Sep 6, 2017 | 1110 | Memorial Sloan Kettering Cancer Center Experience with Paclitaxel in the Treatment of Breast Cancer (Seidman Oct. 1995). Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 9 Download | |
| Sep 6, 2017 | 1122 | Phase II Study of Intravenous Recombinant Humanized Anti p185 HER2 Monoclonal Antibody (rhuMAB HER2) Plus Cisplatin in Patients with HER2 NEU Overexpressing Metastatic Breast Cancer (Pegram Mar. 1995). Download | |
| Sep 6, 2017 | 1127 | Exhibit 1127 Sorenson (1990) Download | |
| Sep 6, 2017 | 1118 | Biweekly Paclitaxel (Taxel) and Cisplatin in Breast and Ovarian Breast Cancer (Gelmon Oct. 1994). Download | |
| Sep 6, 2017 | 1103 | Allan Lipton, M.D., curriculum vitae Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 9 Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 9 Download | |
| Sep 6, 2017 | 1116 | "Excerpts from CLINICAL ONCOLOGY (Martin D. Abeloff et al., eds.,New York Churchill Livingstone, 1995)." Download | |
| Sep 6, 2017 | 1117 | "Inhibitory Effects of Combinations of HER 2 neu Antibody and Chemotherapeutic Agents Used for Treatment of Human Breast Cancers (Pegram 1999)." Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 9 Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 9 Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 9 Download | |
| Sep 6, 2017 | 1101 | U.S. Patent 7,846,441 Download | |
| Sep 6, 2017 | 1121 | Antitumor Activity of Paclitaxel in Combination with Anti-growth Factor Receptor Monoclonal Antibodies in Breast Cancer Xenografts (Baselga Mar. 1994). Download | |
| Sep 6, 2017 | 1126 | Exhibit 1126 Fiebig (1984) Download | |
| Sep 6, 2017 | 1109 | Declaration of Mark X. Sliwkowski (Dec. 10, 1998) Download | |
| Sep 6, 2017 | 1128 | Exhibit 1128 Mattern (1988) Download | |
| Sep 6, 2017 | 1105 | MOLECULAR BIOLOGY OF THE CELL (Bruce 1994) Download | |
| Sep 6, 2017 | 1125 | Cross Resistance and Collateral Sensitivity Studies in Cancer Chemotherapy (Hutchison 1963). Download | |
| Sep 6, 2017 | 1102 | Declaration of Allan Lipton, M.D. Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 7 Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 4 Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 8 Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 3 Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 2 Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History , Vol. 10 Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 6 Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 5 Download | |
| Sep 6, 2017 | 1104 | U.S. Patent 7,846,441 File History, Vol. 1 Download |
